Invincible Vision is a patient-led nonprofit organization focused on serving the Bietti’s Crystalline Dystrophy (BCD) community. It is founded in 2019 in California, U.S. with EIN 84-3660555.
Be a Part of Our Vision
BCD Crystalline Dystrophy (BCD) is a rare, often misdiagnosed genetic eye disease that causes blindness for 100,000 people globally. Right now, there is no proven treatment, but there is hope. With your help, we can push BCD gene therapy research from pre-clinical study to human clinical trials.
Invincible Vision is committed to raising awareness of BCD to advance research for a cure while also supporting its global community of patients, families and friends.
Started by a small group of people touched by BCD, Invincible Vision has quickly grown to include more patients, families, and friends around the world who believe in the invincible vision that we can find a treatment together.
Among the treatment research and developments for BCD, Reflection Biotechnologies’ gene therapy is the most advanced and promising one. Their BCD gene therapy has shown promising results in preclinical studies. Now, they’re working on advancing BCD gene therapy R&D into human clinical trials. This is where you come in!
We need your help to raise awareness for BCD, to support those coping with vision loss, and to fund research to find a treatment, which can ultimately lead to a cure.
Your donation to Invincible Vision will directly advance this gene therapy and any other promising treatment we discover along the way.
Board of Directors
Ismail Ceylan, PhD
Chairman and President
Chief Financial Officer
Molly A. Robb
Partner, Healthcare and Life Sciences, Calibre One